Lyell Immunopharma LYEL
NASDAQ LYEL
$9.26 -0.15 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Accumulated Expenses (2020 - 2026)

Updated

Lyell Immunopharma (LYEL) posted Accumulated Expenses of $35.99 million for Q2 2026, up 28.5% from $28 million a year earlier and up 14.3% from the prior quarter.

Analysis

Lyell Immunopharma (LYEL) Accumulated Expenses (2020 - 2026) Analysis & Trends

At the end of FY2025, Lyell Immunopharma's Accumulated Expenses came in at $46.52 million, up 14.0% from FY2024.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
  • In prior years, Lyell Immunopharma's Accumulated Expenses was $40.82 million in FY2024 (+45.1%), $28.13 million in FY2023 (-2.2%), $28.76 million in FY2022 (-1.0%) and $29.06 million in FY2021 (+3.7%).
  • Quarterly Accumulated Expenses has run from a low of $21.4 million in Q2 2022 to a high of $46.52 million in Q4 2025 over five years.
  • On a year-over-year basis, Accumulated Expenses has increased in each of the last seven quarters, with growth averaging 15.2% over the last eight quarters.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2024, with growth of 45.1%; the weakest was Q2 2022, with a decline of 16.3%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $31.48 million (Q1 2026), $46.52 million (Q4 2025) and $29.31 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Lyell Immunopharma 220.17 Mn 220.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.99 Mn
Mar 31, 2026 31.48 Mn
Dec 31, 2025 46.52 Mn
Sep 30, 2025 29.31 Mn
Jun 30, 2025 28.00 Mn
Mar 31, 2025 31.17 Mn
Dec 31, 2024 40.82 Mn
Sep 30, 2024 29.01 Mn
Jun 30, 2024 25.67 Mn
Mar 31, 2024 24.91 Mn
Dec 31, 2023 28.13 Mn
Sep 30, 2023 29.65 Mn
Jun 30, 2023 24.83 Mn
Mar 31, 2023 22.42 Mn
Dec 31, 2022 28.76 Mn
Sep 30, 2022 23.57 Mn
Jun 30, 2022 21.40 Mn
Mar 31, 2022 22.69 Mn
Dec 31, 2021 29.06 Mn
Sep 30, 2021 25.06 Mn
API Access

Lyell Immunopharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LYEL&period=max&api_key=YOUR_API_KEY